The Dexcom G5 Mobile System is the first CGM System to receive FDA approval to make CGM-based treatment decisions ("non-adjunctive use"). What does this new indication mean?

You are here

It means the Dexcom G5 Mobile can now be used to make diabetes treatment decisions without confirming the reading with a blood glucose meter. Previously, all CGM devices were indicated for use only as a complement (adjunct), not a replacement, for blood glucose meters.

Contact Dexcom

If you are a clinician and want to learn more about Dexcom’s Continuous Glucose Monitoring Systems, please fill out the form and a Dexcom representative will contact you.

If you are a Dexcom User or Patient, please contact Dexcom here.

The information you provide will be sent securely and subject to the Dexcom Terms of Use and Privacy Policy.